Search results
Trulicity, Ozempic, other diabetes drugs in short supply at Erie-area pharmacies
Gannett via AOL· 4 months agoPeople with diabetes who take injectable medications like Trulicity and Ozempic have been scrambling...
Diabetes, weight-loss drugs like Ozempic may lower odds for colon cancer
United Press International via Yahoo News· 6 months agoCould blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also...
Europe to face shortage of Lilly's diabetes drug through September
Reuters via Yahoo News· 9 months agoLike rival Novo Nordisk, Eli Lilly has also been struggling to meet high demand for its diabetes...
What Is Severe Insulin-Resistant Diabetes (SIRD)
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Danielle Weiss, MD Severe insulin-resistant diabetes (SIRD) is a subgroup of type 2 diabetes. While symptoms of SIRD are the same...
Will Acquisitions Help Novo Nordisk (NVO) Combat Stiff Rivalry?
Zacks via Yahoo Finance· 2 years agoDenmark-based Novo Nordisk A/S NVO has one of the broadest diabetes portfolios in the industry. The...
Shortage of diabetes medication forces Georgians to wait months for refills
WSB Cox articles via Yahoo News· 1 year agoA shortage of diabetes medications, like Ozempic, Trulicity and Mounjaro, has diabetic patients...
Lilly sales surge on obesity, diabetes drug demand
BioPharma Dive via Yahoo Finance· 4 months agoSales of Eli Lilly’s diabetes drug Mounjaro exceeded $5 billion in 2023, its first full year on the market, the company said Tuesday, in the latest sign...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 1 month agoDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before...
Here Are 25 Billion Reasons to Invest in Eli Lilly
Motley Fool· 2 years agoEli Lilly (NYSE: LLY) and its shareholders are sitting pretty right now. Eli Lilly owes this performance to a combination of factors. The drugmaker...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Eli Lilly raised its revenue forecast for the year by $2 billion as sales of its GLP-1...
